Versor Investments LP lessened its position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 40.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,302 shares of the company's stock after selling 10,300 shares during the quarter. Versor Investments LP's holdings in DocuSign were worth $950,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also added to or reduced their stakes in the company. Massmutual Trust Co. FSB ADV boosted its position in DocuSign by 5,000.0% during the second quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company's stock valued at $27,000 after buying an additional 500 shares during the period. Mather Group LLC. grew its position in DocuSign by 4,338.5% during the 2nd quarter. Mather Group LLC. now owns 577 shares of the company's stock worth $31,000 after acquiring an additional 564 shares during the last quarter. Reston Wealth Management LLC purchased a new position in DocuSign in the 3rd quarter worth approximately $47,000. nVerses Capital LLC bought a new stake in DocuSign in the second quarter valued at approximately $48,000. Finally, Quarry LP purchased a new stake in shares of DocuSign during the second quarter valued at approximately $53,000. Hedge funds and other institutional investors own 77.64% of the company's stock.
Insiders Place Their Bets
In other DocuSign news, CEO Allan C. Thygesen sold 7,764 shares of the firm's stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $69.95, for a total transaction of $543,091.80. Following the completion of the sale, the chief executive officer now directly owns 107,825 shares in the company, valued at approximately $7,542,358.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other DocuSign news, insider Robert Chatwani sold 14,799 shares of the business's stock in a transaction dated Wednesday, September 18th. The stock was sold at an average price of $55.46, for a total value of $820,752.54. Following the completion of the transaction, the insider now owns 70,748 shares of the company's stock, valued at approximately $3,923,684.08. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Allan C. Thygesen sold 7,764 shares of the firm's stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $69.95, for a total transaction of $543,091.80. Following the sale, the chief executive officer now directly owns 107,825 shares in the company, valued at approximately $7,542,358.75. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 69,558 shares of company stock valued at $4,272,768. 1.66% of the stock is currently owned by corporate insiders.
DocuSign Stock Down 0.8 %
Shares of NASDAQ:DOCU traded down $0.66 during midday trading on Wednesday, reaching $81.81. The company's stock had a trading volume of 2,367,626 shares, compared to its average volume of 2,887,431. The firm has a 50 day moving average of $65.69 and a 200-day moving average of $59.02. The firm has a market capitalization of $16.60 billion, a P/E ratio of 17.53, a PEG ratio of 8.73 and a beta of 0.90. DocuSign, Inc. has a 12-month low of $42.08 and a 12-month high of $83.68.
DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The business had revenue of $736.03 million for the quarter, compared to analysts' expectations of $727.20 million. During the same quarter in the prior year, the company earned $0.09 earnings per share. The business's revenue was up 7.0% compared to the same quarter last year. On average, research analysts predict that DocuSign, Inc. will post 1.01 EPS for the current year.
Analyst Ratings Changes
A number of research firms recently commented on DOCU. Bank of America upped their price target on shares of DocuSign from $60.00 to $68.00 and gave the company a "neutral" rating in a report on Friday, September 6th. Wells Fargo & Company increased their target price on shares of DocuSign from $48.00 to $50.00 and gave the stock an "underweight" rating in a report on Friday, September 6th. Citigroup raised their target price on DocuSign from $86.00 to $87.00 and gave the stock a "buy" rating in a research note on Friday, September 6th. Robert W. Baird increased their price objective on DocuSign from $55.00 to $59.00 and gave the stock a "neutral" rating in a report on Friday, September 6th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $84.00 price objective on shares of DocuSign in a research report on Thursday, September 5th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, DocuSign has an average rating of "Hold" and an average target price of $63.40.
Read Our Latest Research Report on DOCU
About DocuSign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.